Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |